Epizyme

About:

Epizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.

Twitter/X: epizymerx

Top Investors: Royalty Pharma, New Enterprise Associates, Kleiner Perkins, Frazier Healthcare Partners, GlaxoSmithKline

Description:

Epizyme is a biopharmaceutical company located in Cambridge, MA, that is focused on researching treatments for blood cancer and tumors. Founded in late 2007, the company has brought together premier academic and industry leaders to rapidly translate the exciting discoveries emerging from epigenetic research into specific programs that will produce important, novel, molecularly targeted drugs of the future.

Total Funding Amount:

$834M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2007-01-01

Contact Email:

contact(AT)epizyme.com

Founders:

Robert Horvitz, Yi Zhang

Number of Employees:

101-250

Last Funding Date:

2020-01-01

IPO Status:

Public

Industries:

Biopharma

Biotechnology

Health Care